CCCarolina Gomes Coelho

Carolina Gomes Coelho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolina Gomes Coelho has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Disparidades raciais e de sexo na prevalência de multimorbidade por doenças crônicas: estudo transversal, Brasil

    by Nayranne Hivina C. Tavares, Carolina Gomes Coelho, Antonio Augusto Ferreira Carioca, Larissa Fortunato Araújo

    Resumo Objetivo: Examinar disparidades por raça/cor da pele, sexo e sua interseccionalidade na prevalência de multimorbidade entre adultos brasileiros. Métodos: Estudo transversal com adultos participantes da Pesquisa Nacional de Saúde, 2019. A base de dados e o dicionário de variáveis estão disponíveis no site do Instituto Brasileiro de Geografia e Estatística. A multimorbidade (sim/não) foi considerada como a presença simultânea de duas ou mais condições crônicas. Para investigar as associações entre raça/cor da pele (brancos, pardos e pretos), sexo (homens e mulheres), interseccionalidade raça/cor da pele-sexo (homens brancos, homens pardos, homens pretos, mulheres brancas, mulheres pardas e mulheres pretas) e multimorbidade foi utilizada regressão de Poisson com variância robusta. Obtiveram-se razões de prevalência (RP) e seus intervalos de confiança de 95% (IC95%). As análises foram ajustadas para idade e escolaridade. Resultados: Dentre os 57.229 participantes, a prevalência de multimorbidade foi 24,3%. Pessoas pardas (RP 0,92; IC95% 0,87; 0,98) tiveram menores prevalências em comparação às brancas. Mulheres mostraram maior prevalência de multimorbidade em comparação aos homens (RP 1,62; IC95% 1,53; 1,71). A análise interseccional apontou maiores prevalências de multimorbidade entre mulheres brancas (RP 1,58; IC95% 1,46; 1,72), pardas (RP 1,48; IC95% 1,36; 1,60) e pretas (RP 1,55; IC95% 1,39; 1,72), comparadas aos homens brancos. Conclusão: O estudo identificou menor prevalência de multimorbidade entre pardos, e maior entre mulheres. A interseccionalidade revelou que apenas mulheres, independentemente da raça/cor da pele, apresentaram maior prevalência comparadas aos homens brancos. Os achados evidenciaram disparidades por raça/cor da pele e sexo na prevalência de multimorbidade em adultos brasileiros.

  • Open Access

    Race and sex disparities in the prevalence of multimorbidity due to chronic diseases: cross-sectional study, Brazil

    by Nayranne Hivina C. Tavares, Carolina Gomes Coelho, Antonio Augusto Ferreira Carioca, Larissa Fortunato Araújo

    Objective: To examine disparities according to race/skin color and sex, and their intersectionality in the prevalence of multimorbidity among Brazilian adults. Methods: This was a cross-sectional study with adults participating in the 2019 National Health Survey. The database and dictionary of variables are available on the Brazilian Institute of Geography and Statistics website. Multimorbidity (yes/no) was defined as the simultaneous presence of two or more chronic conditions. Poisson regression with robust variance was used to investigate associations between race/skin color (White, Brown and Black), sex (male and female), race/skin color-sex intersectionality (White males, Brown males, Black males, White females, Brown females and Black females), and multimorbidity. Prevalence ratios (PR) and their 95% confidence intervals (95%CI) were obtained. The analyses were adjusted for age and schooling. Results: Among the 57,229 participants, prevalence of multimorbidity was 24.3%. Brown people (PR 0.92; 95%CI 0.87; 0.98) had lower prevalence compared to White people. Females showed a higher prevalence of multimorbidity compared to males (PR 1.62; 95%CI 1.53; 1.71). The intersectionality analysis indicated higher prevalence of multimorbidity among White women (PR 1.58; 95%CI 1.46; 1.72), Brown women (PR 1.48; 95%CI 1.36; 1.60) and Black women (PR 1.55; 95%CI 1.39; 1.72), compared to White men. Conclusion: The study identified lower prevalence of multimorbidity among Brown people, and higher prevalence among females. Intersectionality revealed that only females, regardless of race/skin color, had higher prevalence compared to White males. The findings highlighted disparities according to race/skin color and sex in the prevalence of multimorbidity among Brazilian adults.

  • Open Access

    Dynapenia and sarcopenia: association with the diagnosis, duration and complication of type 2 diabetes mellitus in ELSA-Brasil

    by Débora Noara Duarte dos Santos, Carolina Gomes Coelho, Maria de Fátima Haueisen Sander Diniz, Bruce Bartholow Duncan, Maria Inês Schmidt, Isabela Judith Martins Bensenor, Claudia Szlejf, Rosa Weiss Telles, Sandhi Maria Barreto

    Sarcopenia (the loss of muscle mass, strength and skeletal muscle function) increases mortality and the risk of hospitalization in the older population. Although it is known that older adults with type 2 diabetes mellitus (T2DM) have a higher risk of dynapenia and sarcopenia, few studies have investigated these conditions in middle-aged populations. The objective of this study was to investigate whether T2DM, its duration, the presence of albuminuria, and glycemic control are associated with sarcopenia and its components in adults. The cross-sectional analysis was based on data from visit 2 of the Brazilian Longitudinal Study of Adult Health (2012-2014). The 2018 European Working Group on Sarcopenia in Older People criteria were used to define dynapenia, low appendicular muscle mass (LAMM), and sarcopenia (absent/probable/confirmed). The explanatory variables were: T2DM; duration of T2DM; T2DM according to the presence of albuminuria; and glycemic control (HbA1C < 7%) among people with T2DM. A total of 12,132 participants (mean age = 55.5, SD: 8.9 years) were included. The odds ratio for LAMM was greater among those with T2DM, T2DM duration from 5 to 10 years, and T2DM without albuminuria. Chances of dynapenia were higher among those with T2DM, T2DM duration > 10 years, and T2DM with and without albuminuria. The variables T2DM, T2DM ≥ 10 years, and T2DM with albuminuria increased the odds of probable sarcopenia, and T2DM duration from 5 to 10 years increased the odds of confirmed sarcopenia. The results support the importance of frequently monitoring the musculoskeletal mass and strength of individuals with T2DM to prevent sarcopenia and related outcomes.


  • Open Access

    Birth weight is related with bone mineral content in adulthood: results of ELSA-Brasil

    by Nayranne Hivina Carvalho Tavares, Carolina Gomes Coelho, Sandhi M. Barreto, Luana Giatti, Larissa Fortunato Araújo

    OBJECTIVE: To investigate the association between birth weight and BMC, and whether this relationship differs between men and women. METHODS: A total of 10,159 participants from the ELSA-Brasil cohort were eligible for this analysis. The outcome was the Z-score of the ratio BMC (Kg)/height (m). The exposure was the low birth weight (< 2.5Kg). The magnitude of the associations was estimated by mean differences and their respective 95% confidence intervals (95%CI) using linear regression. All analyses were presented for the total population and stratified by sex. RESULTS: Most were women (54.98%), and the mean age was 52.72 years (SD ± 6.6). In the crude model, we observed that low birth weight was associated with a lower mean BMC/height z-score, compared to adequate birth weight (mean difference: -0.30; 95%CI: -0.39 to -0.21), and this effect was stronger in men (mean difference: -0.43; 95%CI: -0.56 to -0.30) than in women (mean difference: -0.31; 95%CI: -0.44 to -0.19). After adjusting for age, sex per total population, race/skin color, maternal education, individual education, and current weight, there was a considerable reduction in the magnitude of the association (total population: -0.10; 95%CI: -0.14 to -0.06; men: -0.13; 95%CI: -0.21 to -0.06; women: -0.13; 95%CI: -0.21 to -0.05). CONCLUSION: Low birth weight is related to BMC/height z-score in both sexes with no indication of differences by sex. The magnitude of the associations was attenuated after adjustment for the current weight.


  • Open Access

    Body fat distribution and its risk for cardiovascular events in 10 years: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

    by Bárbara Bruna Rodrigues de Oliveira, Carolina Gomes Coelho, Sandhi Maria Barreto, Luana Giatti, Larissa Fortunato Araújo

    Body fat distribution seems to have different effects in cardiovascular diseases (CVD). We aimed to estimate the associations between lower limbs and trunk fat ratio and the 10-year CVD risk, and isolated risk factors in men and women. A total of 10,917 participants from ELSA-Brasil were eligible for this cross-sectional study. Associations between lower limb/trunk fat ratio with the percentage of 10-year CVD risk - according to the Framingham Risk Score - and its risk factors (systolic blood pressure, total cholesterol and HDL-cholesterol, diabetes, and use of antihypertensive medication) were performed using generalized linear models, linear and logistic regressions. All analyses were stratified by gender and adjustments were made by age, self-reported skin color, educational attainment, alcohol consumption, leisure physical activity, hypolipidemic drug use and, for women, menopausal status. In this study, 55.91% were women, with a mean age of 52.68 (SD = 6.57) years. A higher lower limb/trunk fat ratio was related to lower 10-year CVD risk, as well as a reduction in systolic blood pressure, total cholesterol, and antihypertensive drug use, also an increasing HDL-cholesterol in both genders, but this relationship was stronger in women. Besides, a protective relationship to diabetes was observed in women. Higher fat accumulation in the lower body, when compared to the trunk, seems to have a lower risk of CVD and associated risk factors - even in the presence of fat in the abdominal region - with women presenting lower risks than men.


  • Open Access

    Racismo e iniquidade racial na autoavaliação de saúde ruim: o papel da mobilidade social intergeracional no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil)

    by Lidyane V. Camelo, Carolina Gomes Coelho, Dóra Chor, Rosane Harter Griep, Maria da Conceição Chagas de Almeida, Luana Giatti, Sandhi Maria Barreto

    Resumo: Pretos e pardos apresentam grandes desvantagens de saúde, possuem menores chances de ascensão na hierarquia social no curso de vida e menores níveis socioeconômicos do que brancos como resultado do racismo estrutural. Entretanto, pouco se sabe sobre o papel mediador da mobilidade intergeracional na associação entre racismo e saúde. O objetivo do presente estudo foi investigar a associação entre racismo e a autoavaliação de saúde, e verificar em que medida a mobilidade social intergeracional media essa associação. Estudo transversal realizado com dados de 14.386 participantes da linha de base (2008-2010) do Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil). Escolaridade materna, escolaridade do participante, classe sócio-ocupacional do chefe de família e classe sócio-ocupacional do participante compuseram os indicadores de mobilidade social intergeracional (educacional e sócio-ocupacional). Modelos de regressão logística foram utilizados. A prevalência de autoavaliação de saúde ruim foi de 15%, 24% e 28% entre brancos, pardos e pretos, respectivamente. Após ajustes por idade, sexo e centro de investigação foram encontradas maiores chances de autoavaliação de saúde ruim entre pretos (OR = 2,15; IC95%: 1,92-2,41) e pardos (OR = 1,82; IC95%: 1,64-2,01) quando comparados aos brancos. A mobilidade educacional e sócio-ocupacional intergeracional mediaram, respectivamente, 66% e 53% da associação entre a raça/cor e autoavaliação de saúde ruim em pretos, e 61% e 51% em pardos, respectivamente. Resultados confirmam a iniquidade racial na autoavaliação de saúde e apontam que a mobilidade social intergeracional desfavorável é um importante mecanismo para explicar essa iniquidade.


  • Open Access

    O efeito da testagem laboratorial nos indicadores de acompanhamento da COVID-19: uma análise dos 50 países com maior número de casos

    by Flávia Bulegon Pilecco, Carolina Gomes Coelho, Qeren Hapuk Rodrigues Ferreira Fernandes, Ismael Henrique Silveira, Júlia Moreira Pescarini, Naiá Ortelan, Ligia Gabrielli, Estela M. L. Aquino, Maurício Lima Barreto

    Resumo Objetivo Analisar como a testagem da população influencia os indicadores de saúde usados para monitorar a pandemia de COVID-19 nos 50 países com maior número de casos diagnosticados. Métodos Estudo ecológico sobre dados secundários, extraídos em 19/08/2020. Foram calculadas incidência acumulada, taxa de mortalidade, letalidade e proporção de testes positivos. Os dados foram descritos e apresentados graficamente, com o respectivo coeficiente de correlação de Spearman. Resultados A taxa de testagem variou enormemente entre os países. A incidência acumulada e a proporção de testes positivos foram correlacionadas ao número de testes, enquanto a taxa de mortalidade e a letalidade apresentaram correlação baixa com esse indicador. Conclusão A maioria dos países não testa o suficiente para garantir adequado monitoramento da pandemia, com reflexo na qualidade dos indicadores. A ampliação do número de testes é fundamental; porém, ela deve ser acompanhada de outras medidas, como isolamento de casos diagnosticados e rastreamento de contatos.